RETAIN PLANT GROWTH REGULATOR SOLUBLE POWDER Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

retain plant growth regulator soluble powder

valent biosciences a div of sumitomo chemical australia - aminoethoxyvinylglycine - soluble powder - aminoethoxyvinylglycine amino acid-glycine-derivative active 150.0 g/kg - plant regulator - apple | apple - see label for variety | gala apple | stone fruit (see label for exceptions) | delicious | golden delicious | gra - regulate fruiting

KUVAN sapropterin dihydrochloride 100 mg soluble tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

kuvan sapropterin dihydrochloride 100 mg soluble tablet bottle

biomarin pharmaceutical australia pty ltd - sapropterin dihydrochloride, quantity: 100 mg - tablet, soluble - excipient ingredients: sodium stearylfumarate; calcium hydrogen phosphate; mannitol; crospovidone; ascorbic acid; riboflavin - kuvan is indicated for the treatment of hyperphenylalaninemia (hpa) in sapropterin-responsive adult and paediatric patients with phenylketonuria (pku) or tetrahydrobiopterin (bh4) deficiency (see section 4.2 dose and method of administration for definition of sapropterin responsiveness)

SUBOXONE FILM 8/2 buprenorphine (as hydrochloride) 8 mg/naloxone (as hydrochloride dihydrate) 2 mg soluble film sachet Australia - English - Department of Health (Therapeutic Goods Administration)

suboxone film 8/2 buprenorphine (as hydrochloride) 8 mg/naloxone (as hydrochloride dihydrate) 2 mg soluble film sachet

indivior pty ltd - naloxone hydrochloride dihydrate, quantity: 2.44 mg (equivalent: naloxone, qty 2 mg); buprenorphine hydrochloride, quantity: 8.64 mg (equivalent: buprenorphine, qty 8 mg) - soluble film - excipient ingredients: acesulfame potassium; maltitol; polyethylene oxide; citric acid; sunset yellow fcf; hypromellose; sodium citrate; titanium dioxide; propylene glycol; purified water; industrial methylated spirit; flavour - for the treatment of opiate dependence within a framework of medical, social, and psychological treatment.

SUBOXONE FILM 2/0.5 buprenorphine (as hydrochloride) 2 mg/naloxone (as hydrochloride dihydrate) 0.5 mg soluble film sachet Australia - English - Department of Health (Therapeutic Goods Administration)

suboxone film 2/0.5 buprenorphine (as hydrochloride) 2 mg/naloxone (as hydrochloride dihydrate) 0.5 mg soluble film sachet

indivior pty ltd - buprenorphine hydrochloride, quantity: 2.16 mg (equivalent: buprenorphine, qty 2 mg); naloxone hydrochloride dihydrate, quantity: 0.61 mg (equivalent: naloxone, qty 0.5 mg) - soluble film - excipient ingredients: sunset yellow fcf; polyethylene oxide; hypromellose; maltitol; citric acid; acesulfame potassium; sodium citrate; titanium dioxide; propylene glycol; purified water; industrial methylated spirit; flavour - for the treatment of opiate dependence within a framework of medical, social, and psychological treatment.

Prednisolone 5mg soluble tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

prednisolone 5mg soluble tablets

a a h pharmaceuticals ltd - prednisolone sodium phosphate - soluble tablet - 5mg

Prednisolone 5mg soluble tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

prednisolone 5mg soluble tablets

alliance healthcare (distribution) ltd - prednisolone sodium phosphate - soluble tablet - 5mg

Prednisolone 5mg soluble tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

prednisolone 5mg soluble tablets

sigma pharmaceuticals plc - prednisolone sodium phosphate - soluble tablet - 5mg

Prednisolone 5mg soluble tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

prednisolone 5mg soluble tablets

focus pharmaceuticals ltd - prednisolone sodium phosphate - soluble tablet - 5mg